Clonal divergence and genomic meltdown in prostatic pleomorphic giant cell adenocarcinoma
BackgroundPleomorphic giant cell adenocarcinoma (PGCA) of the prostate is a rare, aggressive variant characterized by multinucleated giant cells, sarcomatoid features, and resistance to conventional therapies. Despite its recognition in the WHO 2016 gu…